Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study

HIGHLIGHTS

• who: Guang Cao from the one of the hospitals from June , to October The study was conducted by the Declaration of Helsinki (as revised in, ) and with the ethical approval from the Ethics Committee of Peking University Cancer Hospital and received Institutional Review Board approval. Due to the study`s retrospective nature, the provision of informed consent was waived off by the Ethics Committee of Peking University Cancer Hospital. All the data was collected from the electronic health records, including age, sex, body mass index (BMI), complications of extrahepatic spread, carcinoembryonic antigen (CEA), number of intrahepatic lesions . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.